The global clinical trial report- “2019 Oppositional Defiant Disorder (ODD) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Oppositional Defiant Disorder (ODD). It presents in-depth analysis of Oppositional Defiant Disorder (ODD) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Oppositional Defiant Disorder (ODD).
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Oppositional Defiant Disorder (ODD) clinical trials by- • Current Trial Status • Type of the trial • Sponsor Type • Enrollment Trends • Region • Countries • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Oppositional Defiant Disorder (ODD)
The research work is prepared through extensive and continuous research on Oppositional Defiant Disorder (ODD) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage: • All major trials from 2010 to 2019 and planned trials are included in the report scope. • Drug candidates currently being researched for administering Oppositional Defiant Disorder (ODD) patients are identified • The report includes panorama of Oppositional Defiant Disorder (ODD) clinical trials across the globe • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided • Companies and universities focusing on Oppositional Defiant Disorder (ODD) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status) • Average Enrollment number, insights into enrollment trends, company wise enrollment are included • Both interventional and observational studies are analyzed • News and latest developments for the past one year are presented in the report
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• May 2021
Major players in the individual and family services market are CARE International, Children’s Aid and Family Services Inc., Eastwick Family Services, Executive Healthcare Services (EHS), Feeding America, Goldfields Individual and Family Support Association (GIFSA), Kairos Family Services, North East Independent Living Services, StepStone Family...
The World Health Organization (WHO) made the following statement many years ago, “There is no health without mental health”.Today, as the COVID-19 pandemic ravages the world, another public health crisis is looming over our health systems—that of deteriorating mental health.
Mass unemployment, salary reductions, depleting financial...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Sleep Market Report
The sleep market by revenue is expected to grow at a CAGR of 6.11% during the period 2020–2026.
Several research studies and government programs help improve awareness explaining the importance of sleep in many countries.
120 pages •
By Infiniti Research Limited
• Jun 2021
Global Central Nervous System Disorders Therapeutics Market 2021-2025 The analyst has been monitoring the central nervous system disorders therapeutics market and it is poised to grow by $ 24.35 bn during 2021-2025, progressing at a CAGR of 4.44% during the forecast period. Our report on the central nervous system disorders...
The global behavioral health software market is expected to reach USD 4.9 billion by 2026 from USD 2.0 billion in 2021, at a CAGR of 19.6% during the forecast period. The major factors driving the growth of behavioral health software are the increasing adoption of behavioral health software, availability of government funding, government initiatives...
140 pages •
By Global Industry Analysts
• Apr 2021
- Global Mental Health Software Market to Reach $7.6 Billion by 2027
- Amid the COVID-19 crisis, the global market for Mental Health Software estimated at US$3.4 Billion in the year 2020, is projected to reach a revised size of US$7.6 Billion by 2027, growing at aCAGR of 12% over the period 2020-2027. On-premise,...
Report Scope: The corporate wellness market is segmented into five types. The scope of the report includes an overview of the global market and analyses of global market trends, using 2020 as the base year and forecasting 2021 through 2026 with compound annual growth rate (CAGR) projections. The report discusses...
As people learn to embrace uncertainty, the top trends outlined at the beginning of 2021 will bring about significant changes in the way societies work and live. Changes in user behavior patterns will trigger major growth opportunities influenced by changes in consumption and business models.Emerging advancements in technologies, such as AI...
Scope of the Report The report titled “Global Psychedelic Drugs Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)”, provides an in depth analysis of the global psychedelic drugs market by value, by indication, etc. The report also provides a detailed analysis of the COVID-19 impact on the psychedelic...
Global Emerging Mental Health Devices and Platforms Market to Reach $18,717.5 Million by 2030
Market Report Coverage - Emerging Mental Health Devices and Platforms
• Product Type (Platforms and Devices)
• Application (Stress, Anxiety, Depression, Bipolar Disorder,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.